<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04824599</url>
  </required_header>
  <id_info>
    <org_study_id>LIVFOU-930411</org_study_id>
    <nct_id>NCT04824599</nct_id>
  </id_info>
  <brief_title>Pectoral Nerves Block vs Wound Infiltration for Partial Mastectomy - a Prospective Randomized Trial.</brief_title>
  <official_title>Pectoral Interfascial Plane Block vs Wound Infiltration for Partial Mastectomy - a Prospective Randomized Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karlstad Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karlstad Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pectoralis nerves plane block (PECS) first described by Blanco in 2011 has become part of&#xD;
      postoperative pain management in breast surgery, thoracic surgery and thoracic trauma. The&#xD;
      combination of low complication risk and easiness in mastering of PECS block has made it an&#xD;
      interesting alternative to thoracic epidural anesthesia (TEDA) and paravertebral blockade&#xD;
      (PVB) for pain treatment after breast surgery. Several studies showed good results when PECS&#xD;
      was compared to PVB. PECS blockade however is a procedure requiring some resources in the&#xD;
      operating room. An alternative approach is to inject local anesthetics (LA) in the operation&#xD;
      field by the surgeon.&#xD;
&#xD;
      The hypothesis' tested in this study is primarily: that PECS blockade is superior to LA being&#xD;
      injected by surgeon in the operating field measured by end points such as: post-operative&#xD;
      pain, post-operative analgesics use, post-operative nausea or vomiting (PONV) and length of&#xD;
      stay in the post anesthesia care unit (PACU).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 19, 2021</start_date>
  <completion_date type="Anticipated">March 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>maximal pain in PACU measured with 11 point numerical rating scale (NRS)</measure>
    <time_frame>measured at discharge from PACU (on average 4 hours).</time_frame>
    <description>NRS scale is a validated for assessment of pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximal postoperative nausea and vomiting(PONV) in PACU measured with 11 point numerical rating scale (NRS)</measure>
    <time_frame>measured at discharge from PACU (on average 4 hours).</time_frame>
    <description>PONV NRS similar to pain NRS is an 11 point scale used to estimate severity of postoperative nausea.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative analgesic use</measure>
    <time_frame>measured at 24 hours postoperatively.</time_frame>
    <description>Postoperative analgesic use is related to pain severity and can be a factor leading to increased length of stay in PACU.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in PACU</measure>
    <time_frame>on average 4 hours.</time_frame>
    <description>Is an dependant of multiple factors and an important measurement that can indicate beneficial therapeutic choice.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal pain after discharge from PACU measured with 11 point numerical rating scale (NRS)</measure>
    <time_frame>24 hours</time_frame>
    <description>NRS scale is a validated for assessment of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal postoperative nausea and vomiting(PONV) after discharge from PACU measured with 11 point numerical rating scale (NRS)</measure>
    <time_frame>24 hours</time_frame>
    <description>PONV NRS similar to pain NRS is an 11 point scale used to estimate severity of postoperative nausea.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Breast Neoplasm</condition>
  <arm_group>
    <arm_group_label>PECS+subcutaneus local anesthetic infiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Preoperative ultrasound-led PECS II blockade with ropivacaine 3,75mg/ml (2mg/kg). After surgery - wound infiltration by the surgeon with ropivacaine 2mg/ml (1mg/kg).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local anesthetic infiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Prior to scrubbing surgeon infiltrates the thought incision area with ropivacaine 3,75/ml (1mg/kg). Perioperatively after removal of the tumor follows the deep infiltration of the wound with ropivacaine 3,75mg/ml (2mg/kg).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PECS II</intervention_name>
    <description>Pectoral nerves block (PECS II) is performed with the help of ultrasound. Two injection are performed in two fascial planes. One between pectoralis major muscle and serratus anterior muscle. Second one between pectoralis major and minor muscles.</description>
    <arm_group_label>PECS+subcutaneus local anesthetic infiltration</arm_group_label>
    <other_name>Pectoral nerves block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Local anesthetic infiltration</intervention_name>
    <description>Ropivacaine is administered by surgeon prior to scrubbing and following the removal of the tumor.</description>
    <arm_group_label>Local anesthetic infiltration</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Subcutaneus local anesthetic infiltration</intervention_name>
    <description>Ropivacaine is administered by the surgeon at the end of surgery</description>
    <arm_group_label>PECS+subcutaneus local anesthetic infiltration</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Local anesthetic ropivacaine is administered in both study arms according to the study protocol</description>
    <arm_group_label>Local anesthetic infiltration</arm_group_label>
    <arm_group_label>PECS+subcutaneus local anesthetic infiltration</arm_group_label>
    <other_name>Local anesthetic</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>bk medical Flex Focus 500 Ultrasound Machine</intervention_name>
    <description>Ultrasound with linear probe is performed. Using in-plane technique a correct placement of the injection needle is secured.</description>
    <arm_group_label>PECS+subcutaneus local anesthetic infiltration</arm_group_label>
    <other_name>High Frequency Linear 8870 probe</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women scheduled for partial mastectomy (lumpectomy).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Scheduled cryosection&#xD;
&#xD;
          -  Axillary node dissection&#xD;
&#xD;
          -  Re-resection&#xD;
&#xD;
          -  Age under 18 or unable to give an informed concent&#xD;
&#xD;
          -  Chronic pain history&#xD;
&#xD;
          -  Allergy to local anesthetics&#xD;
&#xD;
          -  History of active drug addiction&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ragnar Henningsson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Örebro University, Sweden</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patryk Eisler</last_name>
    <phone>+46 (0)10 83 15156</phone>
    <email>patryk.eisler@regionvarmland.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ragnar Henningson, PhD</last_name>
    <phone>+46 (0)10 83 17435</phone>
    <email>ragnar.henningsson@regionvarmland.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Central Hospital in Karlstad</name>
      <address>
        <city>Karlstad</city>
        <state>Värmland</state>
        <zip>652 30</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patryk Eisler</last_name>
      <email>patryk.eisler@regionvarmland.se</email>
    </contact>
    <contact_backup>
      <last_name>Ragnar Henningsson, PhD</last_name>
      <email>ragnar.henningsson@regionvarmland.se</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Jacobs A, Lemoine A, Joshi GP, Van de Velde M, Bonnet F; PROSPECT Working Group collaborators#. PROSPECT guideline for oncological breast surgery: a systematic review and procedure-specific postoperative pain management recommendations. Anaesthesia. 2020 May;75(5):664-673. doi: 10.1111/anae.14964. Epub 2020 Jan 26.</citation>
    <PMID>31984479</PMID>
  </reference>
  <reference>
    <citation>Blanco R. The 'pecs block': a novel technique for providing analgesia after breast surgery. Anaesthesia. 2011 Sep;66(9):847-8. doi: 10.1111/j.1365-2044.2011.06838.x.</citation>
    <PMID>21831090</PMID>
  </reference>
  <reference>
    <citation>Apfel CC, Roewer N, Korttila K. How to study postoperative nausea and vomiting. Acta Anaesthesiol Scand. 2002 Sep;46(8):921-8. Review.</citation>
    <PMID>12190791</PMID>
  </reference>
  <reference>
    <citation>Woodworth GE, Ivie RMJ, Nelson SM, Walker CM, Maniker RB. Perioperative Breast Analgesia: A Qualitative Review of Anatomy and Regional Techniques. Reg Anesth Pain Med. 2017 Sep/Oct;42(5):609-631. doi: 10.1097/AAP.0000000000000641. Review.</citation>
    <PMID>28820803</PMID>
  </reference>
  <reference>
    <citation>Habib AS, Kertai MD, Cooter M, Greenup RA, Hwang S. Risk factors for severe acute pain and persistent pain after surgery for breast cancer: a prospective observational study. Reg Anesth Pain Med. 2019 Feb;44(2):192-199. doi: 10.1136/rapm-2018-000040. Epub 2019 Jan 5.</citation>
    <PMID>30700614</PMID>
  </reference>
  <reference>
    <citation>Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP. Validity of four pain intensity rating scales. Pain. 2011 Oct;152(10):2399-2404. doi: 10.1016/j.pain.2011.07.005.</citation>
    <PMID>21856077</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 24, 2021</study_first_submitted>
  <study_first_submitted_qc>March 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>March 27, 2021</last_update_submitted>
  <last_update_submitted_qc>March 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karlstad Central Hospital</investigator_affiliation>
    <investigator_full_name>Patryk Eisler</investigator_full_name>
    <investigator_title>Consultant in Anesthesiology and Intensive care</investigator_title>
  </responsible_party>
  <keyword>Segmental Mastectomy,</keyword>
  <keyword>Analgesia</keyword>
  <keyword>Regional anesthesia</keyword>
  <keyword>Breast surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

